| Dr Lynda C Schneider, MD | |
|
300 Longwood Ave, Boston, MA 02115-5724 | |
| (617) 355-6180 | |
| (617) 730-0310 |
| Full Name | Dr Lynda C Schneider |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 41 Years |
| Location | 300 Longwood Ave, Boston, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891891826 | NPI | - | NPPES |
| 3007880 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KI0005X | Allergy & Immunology - Clinical & Laboratory Immunology | 56019 (Massachusetts) | Primary |
| 208000000X | Pediatrics | 56019 (Massachusetts) | Secondary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Children's Hospital Pediatric Associates, Inc | 3476541830 | 246 |
News Archive
Even before the current financial crisis, there was a growing concern over the fiscal and social sustainability of long-term care for dependent older people. Yet despite these concerns, little is known about basic indicators on this subject. The present publication, "Facts and Figures on Long-term Care - Europe and North America" seeks to bridge that gap of information by bringing together information from international and national sources to present comparable indicators on long-term care.
Children with brain injuries have difficulty developing story-telling skills even though other language abilities, such as vocabulary, tend to catch up with other children as they mature, research at the University of Chicago shows. Our findings suggest that there may be limitations to the remarkable flexibility for language functions displayed by children with brain injuries.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.
› Verified 4 days ago
| Entity Name | Children's Hospital Pediatric Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306664 PECOS PAC ID: 3476541830 Enrollment ID: O20040504000964 |
News Archive
Even before the current financial crisis, there was a growing concern over the fiscal and social sustainability of long-term care for dependent older people. Yet despite these concerns, little is known about basic indicators on this subject. The present publication, "Facts and Figures on Long-term Care - Europe and North America" seeks to bridge that gap of information by bringing together information from international and national sources to present comparable indicators on long-term care.
Children with brain injuries have difficulty developing story-telling skills even though other language abilities, such as vocabulary, tend to catch up with other children as they mature, research at the University of Chicago shows. Our findings suggest that there may be limitations to the remarkable flexibility for language functions displayed by children with brain injuries.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lynda C Schneider, MD 300 Longwood Ave, Fegan Building 6th Floor, Boston, MA 02115-5724 Ph: (617) 355-6117 | Dr Lynda C Schneider, MD 300 Longwood Ave, Boston, MA 02115-5724 Ph: (617) 355-6180 |
News Archive
Even before the current financial crisis, there was a growing concern over the fiscal and social sustainability of long-term care for dependent older people. Yet despite these concerns, little is known about basic indicators on this subject. The present publication, "Facts and Figures on Long-term Care - Europe and North America" seeks to bridge that gap of information by bringing together information from international and national sources to present comparable indicators on long-term care.
Children with brain injuries have difficulty developing story-telling skills even though other language abilities, such as vocabulary, tend to catch up with other children as they mature, research at the University of Chicago shows. Our findings suggest that there may be limitations to the remarkable flexibility for language functions displayed by children with brain injuries.
Fraser Communications, which has designed award-winning campaigns the past six years for First 5 California, won another 3-year contract with the government organization to promote child brain development, early literacy, healthy nutrition, and other critical information for parents of young children.
VENITI, Inc., a company dedicated to providing innovative technology for the treatment of venous disease, announced that it has received approval from the United States Food and Drug Administration (FDA) for an Investigational Device Exemption (IDE) to begin the VIRTUS trial of the VENITI VICI Venous Stent System.
› Verified 4 days ago
Dr. David H. Sachs, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: Bldg. 149-9019, 13th Street, Boston, MA 02466 Phone: 617-726-4065 Fax: 617-726-4067 | |
Dr. Anne Esther Goldfeld, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 800 Huntington Ave, Boston, MA 02115 Phone: 617-278-3351 Fax: 617-278-3454 | |
Dr. Sachin Niranjan Baxi, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 300 Longwood Ave, Fegan 6, Boston, MA 02115 Phone: 617-919-2489 Fax: 617-730-0310 | |
Dr. Richard Arthur Moscicki, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 15 Parkman St, Allergy Associates Wac 626, Boston, MA 02114 Phone: 617-726-3764 Fax: 617-252-7694 | |
Abduarahmn Almutairi, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 300 Longwood Ave, Boston, MA 02115 Phone: 617-355-6117 | |
John L Ohman, MD Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 750 Washington St, Nemc Box 30, Boston, MA 02111 Phone: 617-636-5000 Fax: 617-636-4843 | |
Dr. Paul J. Maglione, MD, PHD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 725 Albany St, Shapiro 9 Suite B, Boston, MA 02118 Phone: 617-638-7480 |